Featured Firms
Presented by BigVoodoo
In early 1997, the U.S. Patent and Trademark Office uncovered a hornet's nest when it announced the likelihood that patent claims would be granted to genomic fragments. Companies filed hundreds of patent applications seeking IP rights to these fragments with bare indications of what they were and what they did. The Patent Gold Rush was on. But like most gold rushes, the dreams of riches from the ownership of genomic data alone began to fade almost as quickly as they arose.
December 10, 2004 at 12:00 AM
1 minute read
The original version of this story was published on Law.Com
Presented by BigVoodoo
The premier educational and networking event for employee benefits brokers and agents.
The Legal Intelligencer honors lawyers leaving a mark on the legal community in Pennsylvania and Delaware.
Consulting Magazine recognizes leaders in technology across three categories Leadership, Client Service and Innovation.
Truly exceptional Bergen County New Jersey Law Firm is growing and seeks strong plaintiff's personal injury Attorney with 5-7 years plaintif...
Shipman is seeking an associate to join our Labor & Employment practice in our Hartford, New Haven, or Stamford office. Candidates shou...
Evergreen Trading is a media investment firm headquartered in NYC. We help brands achieve their goals by leveraging their unwanted assets to...
MELICK & PORTER, LLP PROMOTES CONNECTICUT PARTNERS HOLLY ROGERS, STEVEN BANKS, and ALEXANDER AHRENS